← Master Registry

Published peptide research references

Motixafortide

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. CXCR4 as a therapeutic target in acute myeloid leukemia.

    DOI: 10.1038/s41375-024-02326-3PMID: 39261603

    Source identity and connection checked by Codex (AI).

  2. Motixafortide Acetate.

    DOI: 10.1093/ajhp/zxad253

    Source identity and connection checked by Codex (AI).

  3. Motixafortide: First Approval.

    DOI: 10.1007/s40265-023-01962-w

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Hoy SM
  • Gyawali B
  • Bohlke K
  • Dickter JK
  • Kelkar AH
  • Knopf KB
  • Rapoport BL
  • Roof L
  • Schott S
  • Seshadri MR
  • Shilpakar R
  • Smith TJ
  • Trapani D
  • Woodard AB
  • Cigler T
  • Korbecki J
  • Bosiacki M
  • Kupnicka P
  • Barczak K
  • Chlubek D
  • Baranowska-Bosiacka I